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Objective To compare follicle flushing three times with direct
follicular aspiration in poor responders. Our hypothesis was that
follicle flushing three times in poor responders would result in
similar oocyte yield compared with direct aspiration in poor
responders.
Design A randomised controlled trial performed between January
2015 and June 2015.
Setting University hospital.
Population or sample Eighty eligible poor responders, who were
defined as having five or fewer follicles ≥13 mm in average
diameter with at least two follicles having maximum diameters
>17 mm on the day of human chorionic gonadotrophin
administration. Monofollicular cycles, including natural cycles,
were excluded from the current trial.
Methods In the double-lumen needle group, oocyte retrieval was
performed by flushing three times with 2 ml in each follicle and
in the single-lumen group direct follicle aspiration was performed.
Main outcome measure Number of metaphase II oocytes
retrieved.
Results The mean number of metaphase II oocytes was similar in
both groups (1.9  0.1 versus 2.1  0.1, respectively). The
clinical pregnancy and live birth rates were similar in both groups
(32.5% versus 25% and 25% versus 22.5%, respectively). The only
significant difference between the two groups was the duration of
oocyte retrieval (178.4  13.4 versus 236.3  24.1 seconds,
respectively, P = 0.01).
Conclusion Follicular flushing is time consuming and has similar
results compared with direct follicle aspiration in poor responders.
Keywords follicular flushing, in vitro fertilisation/
intracytoplasmic sperm injection, live birth rate, metaphase II
oocyte, poor responders.
Tweetable abstract Direct follicle aspiration versus flushing in
poor responders yields similar metaphase II oocytes.
Linked article This article is commented on by JM Franasiak, p
1197. To view this mini commentary visit https://dx.doi.org/10.
1111/1471-0528.14628.
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Introduction
Transvaginal oocyte retrieval for assisted reproductive tech-
nologies (ART) is a routine procedure performed under
ultrasound guidance. A 2001 survey reported that >50% of
ART clinics performed routine follicular flushing.1 In theory,
double-lumen retrieval needles are more effective than direct
aspiration, although two recent meta-analyses found that
both needles were similar and capable of collecting oocytes
within follicles.2,3 Previously, we showed that follicular flush-
ing is not superior to direct aspiration in normally respond-
ing patients in the largest reported series.4 Numerous studies
have shown that direct follicle aspiration shortens the oocyte
retrieval procedure time and has similar oocyte yield com-
pared with follicular flushing in normally responding
patients.5–8 Based on these findings, most ART clinics have
changed to direct aspiration needles. However, the efficacy of
follicular flushing was studied in normally respondingTrial registration number NCT 02391155.
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patients. There was no proper randomised study in poor
responders for the evaluation of oocyte retrieval needle com-
parison until the trial by Mok-Lin et al.9
The randomised study of Mok-Lin et al. examined the
effects of follicular flushing in poor responders and showed
that flushing may lead to detrimental effects in terms of a
lower pregnancy rate because of the collection of poor-
quality oocytes, although the total number of retrieved
oocytes was similar.9 Therefore, we aimed to compare in a
randomised trial the oocyte retrieval rate after follicular
flushing using a double-lumen retrieval needle with direct
follicle aspiration needle in poor responders. Our hypothe-
sis was to accept that follicle flushing three times in poor
responders would result in a similar oocyte yield compared
with direct aspiration in poor responders.
Methods
We conducted an open-label, randomised trial in the Divi-
sion of Reproductive Endocrinology and IVF Unit, Depart-
ment of Obstetrics and Gynaecology, Baskent University
Adana, Turkey, from January 2015 to June 2015. The study
was approved by the Ethics Committee of Baskent Univer-
sity (project number 13/161) and by the Turkish Ministry
of Health, Drug and Medical Equipment Department. The
study was registered at clinicaltrials.gov (NCT 02391155)
with the official title of ‘Follicular Flushing Outcomes in
Single- versus Double-lumen Oocyte Retrieval Needles in
Poor Responding Patients.’ Informed consent was obtained
from each patient on the day of oocyte retrieval. The first
patient was enrolled to the study at 11 February 2015.
The study inclusion criteria were women aged 20–
43 years; poor ovarian response was defined as having five or
fewer follicles ≥13 mm in size on the day of human chorionic
gonadotrophin (hCG) administration; serum progesterone
level <1.5 ng/ml on the day of hCG administration; and
known poor functional ovarian reserve to predict a poor
ovarian response to gonadotrophin stimulation diagnosed by
an antral follicle count (AFC) <6 in both ovaries together
with an anti-M€ullerian hormone (AMH) level <0.8 ng/ml.
The study exclusion criteria were monofollicular ovarian
response; natural in vitro fertilisation (IVF) cycle pro-
gramme, and presence of ovarian endometrioma.
The controlled ovarian stimulation protocols were based
on the women’s age, weight, AFC, AMH level and previous
cycle characteristics. Approximately half of the poorly
resonding women (poor responders) took part in a low-
dose luteal gonadotrophin-releasing hormone (GnRH) ago-
nist programme, which consisted of a luteal start with
0.5 mg leuprorelin acetate (Lucrin; Abbott, Paris, France)
until day 2 or 3 following menses, when baseline ultra-
sound scanning and blood testing were performed. After
ovarian suppression was achieved, the dose was reduced to
0.25 mg until the day of 10 000 IU of hCG administration.
If there were no cysts ≥2 cm and the estradiol (E2) level
was <50 pg/ml, then gonadotrophin stimulation with
300 IU (Puregon; MSD, Oss, the Netherlands) was per-
formed. Ultrasound and blood E2 monitoring continued
until the administration of 10 000 IU of hCG when at least
two follicles have reached maximum diameters >17 mm.
The GnRH antagonist protocol involved the administra-
tion of letrozole + recombinant follicle-stimulating hor-
mone (FSH) group. On day 2 or 3 of menses, letrozole
5 mg/day (Femara; Novartis, Basel, Switzerland) was
started and continued for 5 days. The administration of
gonadotrophins was started on the same day with 150 IU
recombinant FSH (Puregon; MSD) plus 150 IU pure
human menopausal gonadotrophin (hMG) (Menopur;
Ferring Pharmaceuticals, Lozan Saint-Prex, Switzerland). A
GnRH antagonist (Orgalutran; MSD) was added to this
regimen when the leading follicle had reached 14 mm.
Ultrasound and blood E2 monitoring continued until the
hCG administration criterion was met, with at least two
follicles having a maximum diameter of >17 mm.
Only four patients were placed on the FSH + pure
hMG/GnRH antagonist protocol, which administered gona-
dotrophins and started on day 2 or 3 of menses with
150 IU recombinant FSH (Puregon; MSD) plus 150 IU
pure hMG (Menopur; Ferring Pharmaceuticals). A GnRH
antagonist (Orgalutran; MSD) was added to this regimen
when the leading follicle reached 14 mm. After the leading
follicle reached >17 mm, 10 000 IU of hCG (Pregnyl
ampoule; MSD) and 0.2 mg/ml triptorelin were injected.
Using a random numbers table, the 80 eligible patients
were assigned randomly to the single-lumen (direct aspira-
tion) or double-lumen needle groups using consecutively
numbered opaque, sealed envelopes on the day of oocyte
retrieval. The random allocation sequence and enrolment
of the participants were performed by the corresponding
author. The envelopes were opened by an individual who
was not associated with the study, generally the attending
nurse. All patients were blinded to the randomisation for
the duration of the study. Clinicians performing the oocyte
retrieval procedure were notified of the treatment alloca-
tion on the day of the retrieval to record duration of pro-
cedure and given anaesthetic drug amounts.
Transvaginal ultrasound-guided oocyte retrieval was per-
formed 36 hours after this dual trigger under sedation with
1% propofol (Fresenius Kabi, Homburg, Germany). For
the single-lumen needle group (n = 40), a 17-gauge needle
(Cook Ireland, Limerick, Ireland) was used to aspirate folli-
cles. A 17-gauge needle (Cook Ireland) was also used in the
double-lumen needle group (n = 40), and 2 ml was
injected into each follicle using a manually pressed syringe
containing 10 ml of culture medium warmed to 37°C and
re-aspirated and re-injected three times for each punctured
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follicle. The pressure at which we aspirated the follicles was
strictly maintained at 80 mmHg.
The oocyte–corona complexes were denuded, and intra-
cytoplasmic sperm injection was performed after a 2-hour
incubation. Embryos were transferred on day 3. Embryo
grading was performed by Hardarson et al.10 All patients
received luteal support with daily intravaginal 90 mg pro-
gesterone (Crinone 8% gel; Merck Serono, Darmstadt, Ger-
many) and 0.1 mg/ml triptorelin on the third day after
embryo transfer.11,12 Clinical pregnancy was defined as the
presence of at least one gestational sac with detectable fetal
cardiac activity by transvaginal ultrasonography. Live birth
was defined as the woman delivered a healthy newborn
baby. The live birth rate is the percentage of all cycles that
lead to live birth.
Our hypothesis was to accept that follicular flushing
three times in poor responders results in similar oocyte
yield compared with direct aspiration in poor responders.
The primary end point of the study was the number of
metaphase II oocytes retrieved. Sample size estimation
determined that 40 women in each group would be
required to demonstrate a one-oocyte increase from three
to four between the two groups with 80% power (b = 0.2
and a = 0.05) with a standard deviation of 1.48 oocytes,
according to Mok-Lin et al.9 Secondary outcomes included
the total number of punctured follicles and retrieved
oocytes, fertilisation rates and implantation rates, duration
of the procedure, and total use of anaesthetic. Additional
outcomes were clinical pregnancy and live birth rate. The
procedure duration was recorded from the injection of
propofol to removal of the needle from the patient after
finishing the last follicle puncture. The data are expressed
as the mean  SD. The baseline differences between the
two groups were analysed using Student’s t-test. Pearson’s
chi-square test and Fisher’s exact test were used to compare
the ratios between groups. A p-value of <0.05 was consid-
ered statistically significant. The data were analysed using
SPSS for Windows (ver. 17.0; SPSS, Chicago, IL, USA).
Results
During the 6-month study period, 867 cycles were per-
formed in our IVF centre, and 156 women were diagnosed
as poor responders. Twelve women were excluded due to
monofollicular/ natural cycles, 16 women were excluded due
to premature progesterone elevation (i.e. progesterone levels
≥1.5 ng/ml on the day of hCG administration), and 48
women declined to take part in the trial. Eighty women con-
sented and were randomised (Figure 1). Table 1 gives the
baseline characteristics of participants, which were similar in
both groups. The mean number of metaphase II oocytes was
similar in the two groups (1.9  0.1 versus 2.1  0.1). The
relative risk for metaphase II oocyte retrieval in the single-
lumen group was estimated as 0.963 (95% CI 0.725–1.279)
and the relative risk for metaphase oocyte retrieval in the
double-lumen group was 1.04 (95% CI 0.772–1.401). The
only significant difference between the two groups was the
duration of oocyte retrieval (178.4  13.4 versus
236.3  24.1 seconds, P = 0.01) (Table 2). The clinical
pregnancy and live birth rates were similar (32.5% versus
25% and 25% versus 22.5, respectively). The implantation
rates were also similar (33.3  8.0% versus 29.6  8.1%)
(Table 3). Embryo transfer procedure was cancelled in 26
women. Of the 13 women in the single-lumen group, no
oocytes were retrieved in four, total fertilisation failure was
detected in four, and embryo cleavage arrest was found in
five women (Table 4). Of the 13 women in the flushing
group, no oocytes were retrieved in two, total fertilisation
failure was detected in six, and cleavage arrest was found in
five (Table 4).
Discussion
Main findings
This is the second randomised controlled trial (RCT) to
show that follicular flushing is time consuming and has
similar results to direct aspiration in poor responders.
Although it is difficult to overcome general beliefs and rou-
tine practice, this trial showed that there is no need to be
anxious when direct aspiration of follicles is used in poor
responders. Our study also showed that there are no detri-
mental effects of flushing of follicles, contrary to Mok-Lin
et al.9
Strength and limitations
The previous RCT suggested that the high intrafollicular
pressure of flushing and longer procedure time resulted
in collection of poor-quality oocytes, which led to lower
implantation and clinical pregnancy rates.9 Although the
previous RCT found no difference in embryo quality in
the two groups, these explanations seemed to be logical;
however, we should remember that these patients were
poor responders, and could therefore produce poor-qual-
ity oocytes. If the high intrafollicular pressure of flushing
affected the oocytes, we would expect to observe poor
embryo quality together with lower implantation and
clinical pregnancy rates in normally responding
patients.4–7 However, the longer procedure time and
anaesthetic agent effects would not impair oocyte quality
in poor responders in the follicular flushing group
because the anaesthetic cannot reach a sufficiently high
intrafollicular concentration during the approximately 5-
minute operation; or impair oocyte quality in such a
short period. We did not have enough power to con-
clude that flushing has detrimental effects on oocyte
quality in terms of pregnancy or live birth rates due to
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Enrolment
867 IVF/ICSI cycles were performed from January 2015 to June 2015
156 patients were diagnosed as poor responders.
12 patients were excluded due to the mono-follicular/natural cycles,
16 patients were excluded from the trial due to premature progesterone elevation
48 patients did not accept to take part in the trial
The eighty eligible patients were assigned randomly into two groups
Allocated to single lumen needle
(n = 40)
Received allocated intervention
(n = 40)
Did not receive allocated intervention
(n = 0)
Allocated to double lumen needle
(n = 40)
Received allocated intervention
(n = 40)
Did not receive allocated intervention
(n = 0)
Allocation
Discontinued intervention (n = 0) Discontinued intervention (n = 0)
Analysed (n = 40) Analysed (n = 40)
Follow-up
Analysis
Figure 1. Flow diagram.
Table 1. Basal characteristics of single-lumen and double-lumen needle groups poor responders
Single-lumen needle
group (n = 40)
Double-lumen needle
group (n = 40)
P
Age (years) (mean  SD) (Median and IQR) 34.3  5.4 (35.5–9.5) 36.2  3.9 (36–16) 0.7
BMI (kg/m2) (mean  SD) (Median and IQR) 25.2  0.7 (24.5–6.7) 27.01  1.0 (25.7–9) 0.1
Duration of infertility (years) (mean  SD) (Median and IQR) 5.2  2.9 (4.0–3.0) 5.51  3.3 (4–5) 0.7
AMH (mIU/l) (mean  SD) (Median and IQR) 0.63  0.10.38–0.54 0.61  0.1 (0.71–0.69) 0.8
Follicle count >14 mm on hCG day (mean  SD) (Median and IQR) 3.3  0.1 (3–1.25) 3.07  0.1 (3–2) 0.1
E2 levels (pg/ml) on hCG day (mean  SD) (Median and IQR) 528.8  54.8 (483–604.7) 476.4  49.9 (441–504) 0.4
Endometrial thickness (mm) (mean  SD) (Median and IQR) 9.9  0.3 (9.6–2.5) 9.4  0.3 (9.8–3.4) 0.2
Total FSH dose (IU) (mean  SD) (Median and IQR) 2636.8  141.0 (2700–900) 2631.2  179.9 (2662.5–1425) 0.9
GnRH agonist cycles 47.5% (19/40) 57.5% (23/40) 0.5
GnRH antagonist cycles 5% (2/40) 5% (2/40) 0.9
Letrozol + FSH/GnRH Antagonist Cycles 47.5% (19/40) 37.5% (15/40) 0.6
BMI, body mass index; GnRH, gonadotrophin-releasing hormone; IQR, interquartile range; SD, standard deviation.
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the small numbers of patients. Much larger studies (in-
cluding 200–800 per group) would be needed to properly
assess clinical pregnancy and live birth outcomes.
There was no difference in flushing pressure between our
study and the first RCT, but Mok-Lin et al. used larger
needles (16-gauge), which might aspirate greater numbers
of immature oocytes. Furthermore, they used four flushes,
which was a greater number of injections and re-aspira-
tions. We used three flushes in the double-lumen group.
These were main the differences between the studies. In
fact, Mok-Lin et al. reported contradictory results com-
pared with RCTs of normally responding women and nee-
dle type. However, similar to our study, a recent trial on
follicular flushing and ART outcomes demonstrated that
flushing has no detrimental effects on fertilisation rate,
embryo quality and pregnancy rate.13
In the current RCT, we excluded poor reserve women
with endometrioma. The ART outcomes of women with
endometrioma differ from those in women without
endometrioma.14 Although the AFC is reduced in ovaries
with endometrioma, the oocyte retrieval rate is similar in
ovaries without endometrioma.15,16 We measured both
AMH and AFC, which seemed to be lower in endometri-
oma patients who were excluded from the current RCT.
We selected patients with five or fewer follicles ≥13 mm in
size on the day of hCG administration to obtain a homoge-
neous sample size for fertilisation and cleavage rates.
Although follicular flushing seemed to be effective in
small-diameter follicles in the trial of Mehri et al.,17 the
fertilisation and cleavage rates were reduced in small diam-
eter follicles when compared with larger (>18 mm) diame-
ter follicles.17
As with the previous RCT, our study has a limitation in
terms of evaluating pregnancy and implantation rates
because of the relatively small sample size. Another limita-
tion was the exclusion of monofollicular/natural cycles. A
previous study demonstrated that follicular flushing in
monofollicular/natural cycles resulted in a significant
Table 2. Oocyte retrieval and embryology laboratory outcomes of poor responder women in single- and double-lumen needle groups
Single-lumen needle
group (n = 40)
Double-lumen needle
group (n = 40)
P 95% CI
Total follicles aspirated 124 123 0.1
Numbers of total oocytes 93 94 0.1
Retrieved oocytes (mean  SD) (Median and IQR) 2.3  0.2 (2.5–1) 2.3  0.2 (3–1) 0.1 0.4 to 0.5
M II oocyte numbers (mean  SD) (Median and IQR) 1.9  0.1 (2–1.25) 2.1  0.1 (3–1) 0.2 0.66 to 0.26
Numbers of GV (mean  SD) 0.07  0.04 0.05  0.03 0.6
Duration of OR (seconds) (mean  SD) (Median and IQR) 178.4  13.4 (138.5–102.5) 236.3  24.1 (230–130) 0.01 113.3 to –2.5
Total anaesthetics used (mean  SD) (Median and IQR) 11.08  3.8 (5–1) 11.8  5 (5–0) 0.1 1.3 to 0.2
Fertilisation rates (%) (mean  SD) (Median and IQR) 66.1  5.7 (100–50) 63.1  5.9 (100–50) 0.7 13.8 to 12.6
Numbers of cleavage (mean  SD) (Median and IQR) 1.5  0.1 (1.5–1) 1.5  0.1 (2–2) 0.6 0.45 to 0.27
Embryo numbers (mean  SD) (Median and IQR) 1.5  0.1 (1.5–1) 1.5  0.1 (2–2) 0.8 0.4 to 0.3
Number of transferred embryos (mean  SD) (Median and IQR) 1.3  0.1 (1–1) 1.3  0.09 (1–1) 0.7 0.23 to 0.3
Number of Grade 1 ET (mean  SD) (Median and IQR) 0.6  0.1 (0–1) 0.5  0.1 (0–1) 0.5 0.25 to 0.48
Number of Grade 2 ET (mean  SD) (Median and IQR) 0.8  0.1 (1–1) 0.9  0.1 (2–1) 0.2 0.52 to 0.3
ET, embryo transferred; GV, germinal vesicle; IQR, interquartile range.
Table 3. IVF/intracytoplasmic sperm injection outcomes of poor responders who received direct aspiration and flushing at oocyte retrieval
Single-lumen needle
group (n = 40)
Double-lumen
needle group (n = 40)
P RR with 95% CI
Positive b-hCG 15 (37.5%) 10 (25%) 0.3 0.76–1.58
Clinical pregnancy rate 13 (32.5%) 10 (25%) 0.8 0.74–1.49
Implantation rate (%) 33.3  8.0 29.6  8.12 0.7 0.82–1.27
Singleton pregnancy rate 12 /13 (92.3%) 10 (100%) 1 0.73–1.46
Twin pregnancy rate 1/13 (7.69%) 0 1 0.74–1.38
Live birth rate 10/40 (25%) 9/40 (22.5%) 1 0.72–1.42
Cancel rate 13 (32.5%) 13 (32.5%) 1 0.71–1.41
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increase in oocyte yield and transferrable embryos.18 Actu-
ally, this is for the poorest responders and candidates for
donor programmes. Furthermore, these patients have the
lowest clinical pregnancy rates and implantation rates. If
we considered clinical pregnancy/implantation rates in the
poorest responders, we would not be able to achieve our
main goal of evaluating technique efficacy.
Interpretation
As in our previous RCT and the meta-analysis, our current
RCT found neither detrimental nor beneficial effect of fol-
licular flushing three times on mature oocyte yield in poor
responders.2–4 An animal study showed that needle type
did not affect oocyte yield, although twisting the needle
within the follicle seemed to be effective in a single-lumen
aspiration group in cattle.19
Conclusion
This is the second RCT to indicate that there is no need
for anxiety about using a single-lumen needle in patients
with few follicles (poor responders) in terms of mature
oocyte yield. Additional RCTs are needed to draw conclu-
sions in terms of pregnancy and live birth rates.
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